TCL Archive NIH Reauthorization Compromise Between House and Senate Gives NCI Three Year Authorization Period October 18, 1985
TCL Archive In Brief: David Feigal To Head FDA’s Antiviral Division; ODAC To Discuss Melphalan, Amifostine NDAs January 17, 1992
TCL Archive NIH oncology peer reviewers are protesting the outcome of a recent meeting in which their own grant applications fared so poorly that the reviewers said they were penalized for their service. May 6, 2005
